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Abstract
We present the case of pleiomorphic liposarcoma in the medial compartment of the thigh of a 59-year-old
female patient. The lump was noticed eight months prior to presentation and had gradually increased in
size, leading to pressure symptoms in her thigh. Although painless initially, the lump eventually became
tender prompting her to seek surgical attention. At the plastic surgery clinic, she was advised to get an MRI,
which revealed an irregular but well-defined mass lesion measuring 8.2 x 6.6 x 4.3 cm. The mass did not
have any manifestations in the surrounding structures. A wide excisional biopsy was then performed, and
multiple sections were processed for histopathological analysis, confirming a diagnosis of epithelioid variant
of pleomorphic liposarcoma.
Categories: Plastic Surgery, Oncology, Orthopedics
Keywords: aggressive sarcoma, surgery, plastic and reconstructive surgery, soft tissue tumours, pleomorphic
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Introduction
Liposarcoma is the most common malignant soft tissue tumour in adults. They are mesenchymal in origin
and are usually large, occurring most frequently in the lower extremities (popliteal fossa and medial thigh),
retroperitoneal, perineal and mesenteric region and shoulder area [1]. The common morphological
denominator of liposarcoma is the lipoblasts [1,2]. These appear as mono or multinucleated cells with mono
or multi-cytoplasmic vacuoles that contain lipids [3]. Liposarcoma can be differentiated into four subtypes:
(1) Atypical lipomatous well-differentiated liposarcoma (ALT/WDLS); (2) Dedifferentiated liposarcoma
(DLS); (3) Myxoid liposarcoma (MLS) and (4) Pleomorphic liposarcoma (PLS) [4]. PLS is the rarest subtype as
it comprises only 5-10% of all lipomatous tumours. It typically occurs in adults aged 50 or above and mostly
arises in the deep soft tissue of extremities more than retroperitoneal. PLS also has the highest LS tumour-
associated mortality occurring up to 50% of patients. It also has the highest malignancy grade, tissue-
invasion, metastatic nature and recurrence rate [4]. Complete surgical resection is challenging but at
present, the most successful and only recognised treatment for PLS. Unresectable tumours are managed with
radio and chemotherapy, which reduce recurrence but have shown to have no effect on mortality [5]. In
addition, histopathology determines the prognostic implications for all lipomatous tumours [1,4,6]. Herein,
we present the case of a 59-year-old female with an LPS in her right medial thigh with hepatic, skeletal and
pulmonary metastasis. There is limited reporting of such cases in medical literature, highlighting the
importance of further research to improve the diagnosis and management of PLS, especially the cases
associated with distant metastases.
Case Presentation
A 59-year-old female patient presented to a plastic surgery clinic with a lump on her right medial thigh. She
noticed the lump eight months ago and it was gradually increasing in size. It was painless initially; however,
the lump gradually became tender. The patient was otherwise fit and well with no co-existing morbidities.
Closer examination of the right thigh revealed a high consistency mass, with reduced mobility. There was no
right inguinal lymphadenopathy or lymph nodes enlargement. 
Laboratory blood tests were unremarkable. An MRI scan was requested to further assess the mass, which was
irregular but well-defined in the medial compartment of the thigh, measuring 8.2 x 6.6 x 4.3 cm in size. The
mass showed an intermediate signal on both T1 and T2-weighted imaging, appearing hyperintense
compared to the adjacent muscular tissue, which also persisted on fat-suppressed imaging. The mass
invaded the intramuscular fat planes and caused compression and displacement of the adductor muscles.
There was no evidence of intra-muscular invasion. Normal cortical outline and medullary signal intensity of
the femur were seen in the right thigh. There was no evidence of bone contusion, marrow oedema, fracture
line, or cortical discontinuity. Other muscles of the thigh had a normal outline and signal intensity with no
evidence of focal or diffuse oedema. Neurovascular structures were unremarkable. Overall, MRI findings
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were suggestive of soft tissue neoplasm, with a possibility of a neurogenic tumour. A wide excisional biopsy
was then performed to further assess the tissue histologically by the pathologist and confirm the diagnosis.
The removed mass measuring 8.5 x 6.5 x 5.4 cm and is shown in Figure 1. The mass had a smooth outer
surface and a soft consistency. The cut surface showed a homogenous tan-white appearance with some slit-
like spaces and occasional haemorrhagic spots. Multiple sections were processed for histopathological
examination from different planes.
FIGURE 1: Wide excisional biopsy revealed a smooth mass with soft
consistency, measuring 8.5 cm x 6.5 cm x 5.4 cm
Histopathology of the mass revealed a tumour arranged in sheets and fascicles composed of round to oval
cells along with variably sized adipocytes (Figure 2). Numerous interspersed lipoblasts with indented nuclei
were also seen. Moreover, severe nuclear atypia was noted including bizarre cells (Figure 3 and Figure 4). An
area of necrosis was seen with a few areas, which showed malignant and fibrous histiocytoma-like features.
Furthermore, a few thin-walled dilated and congested blood vessels were also noted. Also, brisk mitosis was
noted (35-38 per 10 HPF) (Figure 5). Immunohistochemical staining (IHC) was also performed and the
tumour cells were diffusely positive for vimentin and focally positive for S-100; while negative for creatine
kinase (CK), smooth muscle antigen (SMA), desmin, CD34 and MyoD1. Overall, the pathological findings are
all suggestive features of a high-grade sarcoma, favouring the epithelioid variant of PLS.
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FIGURE 2: The section shows sheets of adipocytes in low power (10x) –
Hematoxylin and Eosin stain (H&E)
FIGURE 3: High power magnification (40x) showing numerous lipoblasts
with severe nuclear atypia/ bizarre cells and abnormal mitotic figures –
Hematoxylin and Eosin stain (H&E)
FIGURE 4: High power magnification (40x) showing numerous lipoblasts
with severe nuclear atypia/ bizarre cells and abnormal mitotic figures –
Hematoxilin and Eosin stain (H&E)
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FIGURE 5: The section shows dilated and congested blood vessels –
Hematoxylin and Eosin stain (H&E)
The patient was also referred to the Department of Nuclear Medicine & Molecular Imaging for post-surgical
restaging and assessment for possible metastases using 18F-fluorodeoxyglucose positron emission
tomography-computed tomography (18F-FDG PET-CT) scan. The abdominopelvic section showed the liver
measuring within normal limits; however, the scan revealed an ill-defined hypermetabolic hypodense lesion
seen involving segment VI measuring approximately 2.8 x 1.8 cm suggestive of hepatic metastases with
concurrent fatty liver. The scan was also remarkable for the musculoskeletal system, revealing multiple
hypermetabolic osseous lesions involving the skull base, right iliac bone, and few vertebrae (predominantly
T7-L1); which was suggestive of skeletal metastases. A non-hypermetabolic pulmonary nodule in the right
lung field was also detected; it was considered to be likely benign, but interval scanning is suggested to
monitor further progress. Finally, there was also evidence of diffuse subtle hypermetabolism at the site of
surgery which is suggestive of postsurgical inflammatory sequelae; however, microscopic residual disease
cannot be completely ruled out. These multi-organ lesions were due to be biopsied to examine their
immunohistochemical findings to confirm metastatic lesions of primary pleiomorphic liposarcoma.
However, the patient did not attend the follow-up appointments.
Discussion
PLS represents the rarest type of liposarcomas [7]. Due to the dearth of literature in the area, diagnosis and
treatment of PLS are still significant challenges for clinicians [7,8]. The single most important feature in the
diagnosis of PLS is the presence of pleomorphic lipoblasts, the proportion of which varies significantly
among cases [9]. That being said, diagnosis of PLS comes with many closely related differentials such as DLS,
pleomorphic leiomyosarcoma, pleiomorphic rhabdomyosarcoma, pleomorphic malignant peripheral nerve
sheath tumour, and malignant fibrous histiocytoma [8-10]. Although some immunohistochemical markers
and ultrastructural evaluation can be used to exclude the alternative diagnoses, careful attention to
microscopic detail and the recognition of pleomorphic lipoblasts are the major determinants of the
diagnosis [9-12]. 
Several differential diagnoses were excluded following our IHC. Pleomorphic lipoma, for instance, which
usually presents as a well-circumscribed mass shows strong immunoreactivity to CD34 (reported negative in
this case). Furthermore, other closely resembling carcinomas such as renal cell carcinomas were excluded
owing to the negative epithelial membrane antigen test. MFH and other pleomorphic non-lipogenic
sarcomas were excluded based on the presence of lipoblasts in this case. Furthermore, as this case
demonstrated a significant degree of pleomorphism, myxoid liposarcoma was safely excluded. DLS is
another closely related differential; however, the abundance of lipoblasts associated with bizarre nuclei and
irregular nuclear membranes pointed towards PLS. Furthermore, the location of the lesion in the extremities
is far more common in PLS than in DDLPS, which is mostly found retroperitoneally [8]. As reported in this
case, the epithelioid variant of PLS, which represents only around 10% of all PLS, is characterized by a sheet-
like arrangement of epithelioid cells with abundant eosinophilic cytoplasm. Less obvious adipocytic
differentiation and focal positivity for S-100 increases potential for misdiagnosis as carcinoma or melanoma,
further highlighting the importance of the pathologist’s attention to detail for an accurate diagnosis. 
The mainstay of treatment for soft tissue sarcomas remains complete surgical resection to minimize the risk
of recurrence [5,13-15]. This may or may not be accompanied by radiotherapy and chemotherapy [5]. Several
factors play a role in determining the prognosis of the case; histologic grade, reflected in the grade of
differentiation, remains the most important prognostic factor. Low-grade myxoid variants have a five-year
survival rate of 90%, while high-grade lipomatous tumours such as round cell and PLSs have survival rates
of 60% and 30-50% [5]. Distant metastasis also plays a major role in the prognostics of the patient. While
low-grade liposarcomas rarely metastasize, PLS, especially those in the deep-seated tissues of the lower
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extremities, tend to show early metastasis to the lungs in 75% of cases [5]. Bone metastases, on the other
hand, is rarer in soft tissue sarcomas and varies significantly among histological subtypes; PLS,
leiomyosarcoma, and angiosarcoma showed the highest incidence of bone metastasis, where axial skeleton
is affected in 70% of the cases [5,6,13-15]. However, as displayed in this case, liver metastasis is extremely
rare as medical literature has only reported two cases of isolated liver metastasis in PLS [5,6]. In most soft
tissue sarcomas, adjuvant chemotherapy following surgery has been proved to be of dubious value; however,
in high-grade sarcomas with tumour size > 5cm and widespread metastasis, chemotherapy use has been
justified even though it is associated with complications such as delayed wound healing [5].
Conclusions
PLS has the highest mortality rate among the four subtypes of liposarcomas, highlighting the importance of
early and accurate diagnosis. Although IHC can be used in excluding other diagnoses, careful microscopic
examination of the lipoblasts demonstrates that lipoblasts are indeed “in the eye of the beholder”. In terms
of management, low-grade liposarcomas (well-differentiated and myxoid) can be largely managed with
surgery alone provided the surgery is carefully planned and adequate clean margins are achieved. However,
high-grade liposarcomas (round cell and pleomorphic), especially in extremities need to often be managed
with neoadjuvant/adjuvant chemotherapy and radiation. Metastasis remains a considerable concern in high-
grade liposarcomas, however, the paucity of literature in the area shows the need for more extensive
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